《新股消息》百心安(02185.HK)今日起招股 入場費12,388.59元
中國創新介入式心血管裝置公司百心安-B(02185.HK)公布,計劃全球發售1,793.7萬股H股,當中香港公開發售佔10%,國際發售佔90%,由今日(16日)起招股,本周五(19日)中午截止。每股招股價介乎21.26至24.53元,每手500股,入場費約12,388.59元,預計於11月26日掛牌。華泰國際為獨家保薦人。
以招股價中位數22.9元計,公司料集資淨額約3.45億元,當中62%擬用作撥付正在進行的確認性臨床試驗、註冊備案的籌備事宜以及核心產品Bioheart的計劃中商業化上市;21.3%用作撥付在中國正在進行的隨機對照臨床試驗以及腎神經阻斷在研產品第二代Iberis的持續開發;6.7%用於撥付管線中其他在研產品的研發、進行中臨床前研究及已規劃的臨床試驗;10%作一般企業及營運資金用途。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.